<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1728-8800-2015-3-82-88</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-146</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>ПРОБЫ С ДОЗИРОВАННОЙ ФИЗИЧЕСКОЙ НАГРУЗКОЙ В КАРДИОЛОГИИ: ПРОШЛОЕ, НАСТОЯЩЕЕ И БУДУЩЕЕ. ЧАСТЬ II</article-title><trans-title-group xml:lang="en"><trans-title>EXERCISE TESTS IN CARDIOLOGY: PAST, PRESENT AND FUTURE. PART II</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воронина</surname><given-names>В. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Voronina</surname><given-names>V. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к. м.н., с. н.с. отдела профилактической фармакотерапии,</p></bio><email xlink:type="simple">vvoronina@gnicpm.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Киселева</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kiseleva</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к. м.н., в. н.с. отдела эпидемиологии ХНИЗ</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Марцевич</surname><given-names>С. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Martsevich</surname><given-names>S. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д. м.н., профессор руководитель отдела профилактической фармакотерапии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ "Государственный научно-исследовательский центр профилактической медицины Минздрава России. Москва, Россия</institution></aff><aff xml:lang="en"><institution>FSBI "State Scientific-Research Center for Prevention Medicine" of the Healthcare Ministry. Moscow, Russia</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>20</day><month>06</month><year>2015</year></pub-date><volume>14</volume><issue>3</issue><fpage>82</fpage><lpage>88</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Воронина В.П., Киселева Н.В., Марцевич С.Ю., 2015</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="ru">Воронина В.П., Киселева Н.В., Марцевич С.Ю.</copyright-holder><copyright-holder xml:lang="en">Voronina V.P., Kiseleva N.V., Martsevich S.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/146">https://cardiovascular.elpub.ru/jour/article/view/146</self-uri><abstract><p>Во второй части обзора обсуждаются основные принципы проведе­ния проб с физической нагрузкой, протоколы нагрузочных проб, прогностическое значение показателей нагрузочных проб у боль­ных ишемической болезнью сердца. Рассматриваются вопросы применения результатов проб с физической нагрузкой для опреде­ления предтестовой вероятности диагностики ишемической болез­ни сердца, стратификации риска сердечно-сосудистых осложне­ний, оценки эффективности лечения и прогноза.</p><sec><title> </title><p> </p><p> </p></sec></abstract><trans-abstract xml:lang="en"><p>The second part of the review focuses on the main principles of exercise tests, protocols of exercise tests, prognostic significance of the values obtained in ischemic heart disease. The problems are accounted on how to use the results of exercise tests for pretest probability of ischemic heart disease, to stratify the risk of cardiovascular complications, to evaluate the efficacy and prognosis.</p><p> </p></trans-abstract><kwd-group xml:lang="ru"><kwd>ЭКГ-нагрузочные пробы</kwd><kwd>прогностические индексы</kwd><kwd>ишемическая болезнь сердца</kwd><kwd>прогноз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>ECG-exercise tests</kwd><kwd>prognostic indexes</kwd><kwd>ischemic heart disease</kwd><kwd>prognosis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Литературу с 1 по 41 источник смотрите в I части статьи в журнале Кардиоваскулярная терапия и профилактика 2015; 14(2): 80-7.</mixed-citation><mixed-citation xml:lang="en">Литературу с 1 по 41 источник смотрите в I части статьи в журнале Кардиоваскулярная терапия и профилактика 2015; 14(2): 80-7.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Marcevich SJu, Zagrebel'nyj AV, Kutishenko N. Transient myocardial ischemia in patients with chronic ischemic heart disease: a comparison of different methods to identify signs, Kardiologiia 2000; 11: 9-12. Russian (Марцевич С. Ю., Загребельный А. В., Кутишенко Н. П. Преходящая ишемия миокарда у больных хронической ишемической болезнью сердца: сравнение различных признаков и методов выявления. Кардиология 2000; 11: 9-12).</mixed-citation><mixed-citation xml:lang="en">Marcevich SJu, Zagrebel'nyj AV, Kutishenko N. Transient myocardial ischemia in patients with chronic ischemic heart disease: a comparison of different methods to identify signs, Kardiologiia 2000; 11: 9-12. Russian (Марцевич С. Ю., Загребельный А. В., Кутишенко Н. П. Преходящая ишемия миокарда у больных хронической ишемической болезнью сердца: сравнение различных признаков и методов выявления. Кардиология 2000; 11: 9-12).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Koltunov IE, Mazaev VP, Marcevich SJu. A comprehensive evaluation of the results of samples with measured physical load on the treadmill for stratifying patients into risk groups Cardiovascular Therapy and Prevention 2003; 3: 49-52. Russian (Колтунов И. Е., Мазаев В. П., Марцевич С. Ю. Комплексная оценка результатов проб с дозированной физической нагрузкой на тредмиле для стратификации больных на группы риска. Кардиоваскулярная терапия и профилактика 2003; 3: 49-52).</mixed-citation><mixed-citation xml:lang="en">Koltunov IE, Mazaev VP, Marcevich SJu. A comprehensive evaluation of the results of samples with measured physical load on the treadmill for stratifying patients into risk groups Cardiovascular Therapy and Prevention 2003; 3: 49-52. Russian (Колтунов И. Е., Мазаев В. П., Марцевич С. Ю. Комплексная оценка результатов проб с дозированной физической нагрузкой на тредмиле для стратификации больных на группы риска. Кардиоваскулярная терапия и профилактика 2003; 3: 49-52).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Mihajlov VM. Stress Testing ECG monitoring: bicycle ergometry, treadmill test, step test, walking. Ivanovo: A Grief, 2005. 440 p. Russian (Михайлов В. М. Нагрузочное тестирование под контролем ЭКГ: велоэргометрия, тредмил-тест, степ-тест, ходьба. Иваново: А-Гриф, 2005; 440 с).</mixed-citation><mixed-citation xml:lang="en">Mihajlov VM. Stress Testing ECG monitoring: bicycle ergometry, treadmill test, step test, walking. Ivanovo: A Grief, 2005. 440 p. Russian (Михайлов В. М. Нагрузочное тестирование под контролем ЭКГ: велоэргометрия, тредмил-тест, степ-тест, ходьба. Иваново: А-Гриф, 2005; 440 с).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Working group on guidelines of European Society of Cardiology. Guidelines for treatment of stable coronary heart disease. ESC 2013. Russ J Cardiol 2014; 7(111): 7-79. Russian (Рабочая группа по лечению стабильной ишемической болезни сердца Европейского общества кардиологов. Рекомендации по лечению стабильной ишемической болезни сердца. ESC 2013. Российский кардиологический журнал 2014; 7(111): 7-79).</mixed-citation><mixed-citation xml:lang="en">Working group on guidelines of European Society of Cardiology. Guidelines for treatment of stable coronary heart disease. ESC 2013. Russ J Cardiol 2014; 7(111): 7-79. Russian (Рабочая группа по лечению стабильной ишемической болезни сердца Европейского общества кардиологов. Рекомендации по лечению стабильной ишемической болезни сердца. ESC 2013. Российский кардиологический журнал 2014; 7(111): 7-79).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Diamond GA, Forrester JS. Analysis of Probability as an Aid in the Clinical Diagnosis of Coronary-Artery Disease N Engl J Med 1979; 300; 24: 1350-8.</mixed-citation><mixed-citation xml:lang="en">Diamond GA, Forrester JS. Analysis of Probability as an Aid in the Clinical Diagnosis of Coronary-Artery Disease N Engl J Med 1979; 300; 24: 1350-8.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Fletcher GF, Balady GJ, Amsterdam EA, et al. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation 2001; 104; 14: 1694-740.</mixed-citation><mixed-citation xml:lang="en">Fletcher GF, Balady GJ, Amsterdam EA, et al. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation 2001; 104; 14: 1694-740.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Lupanov VP. Prognosis of patients with coronary (ischemic) heart disease. Russ J Cardiol 1997; 2: 12-7. Russian (Лупанов В. П. Прогноз больных коронарной (ишемической) болезнью сердца. Российский кардиологический журнал 1997; 2: 12-7).</mixed-citation><mixed-citation xml:lang="en">Lupanov VP. Prognosis of patients with coronary (ischemic) heart disease. Russ J Cardiol 1997; 2: 12-7. Russian (Лупанов В. П. Прогноз больных коронарной (ишемической) болезнью сердца. Российский кардиологический журнал 1997; 2: 12-7).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Dawber TR, Meadors GF, Moore FE. Epidemiological Approaches to Heart Disease: The Framingham Study . American Journal of Public Health and the Nations Health. 1951; 41(3): 279-86.</mixed-citation><mixed-citation xml:lang="en">Dawber TR, Meadors GF, Moore FE. Epidemiological Approaches to Heart Disease: The Framingham Study . American Journal of Public Health and the Nations Health. 1951; 41(3): 279-86.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Mjasnikov AL. Hypertensive heart disease and atherosclerosis. Moscow: Medicine, 1965; 515 p. Russian (Мясников А. Л. Гипертоническая болезнь и атеросклероз. Москва: Медицина 1965; 515 с).</mixed-citation><mixed-citation xml:lang="en">Mjasnikov AL. Hypertensive heart disease and atherosclerosis. Moscow: Medicine, 1965; 515 p. Russian (Мясников А. Л. Гипертоническая болезнь и атеросклероз. Москва: Медицина 1965; 515 с).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Epstein FH, Block WD, Hand EA, Francis T. Familial hypercholesterolemia, xanthomatosis and coronary heart disease. Am J Med 1959; 26(1): 39-53.</mixed-citation><mixed-citation xml:lang="en">Epstein FH, Block WD, Hand EA, Francis T. Familial hypercholesterolemia, xanthomatosis and coronary heart disease. Am J Med 1959; 26(1): 39-53.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Keys A. Coronary heart disease in seven countries. 1970. Nutrition. 1997; 13(3): 250-2.</mixed-citation><mixed-citation xml:lang="en">Keys A. Coronary heart disease in seven countries. 1970. Nutrition. 1997; 13(3): 250-2.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case- control study. Lancet 2004; 364(9438): 937-52.</mixed-citation><mixed-citation xml:lang="en">Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case- control study. Lancet 2004; 364(9438): 937-52.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Oganov RG. The concept of risk factors as a basis of prevention of cardiovascular diseases. Vrach 2001; 7: 3-6. Russian (Оганов Р. Г. Концепция факторов риска как основа профилактики сердечно-сосудистых заболеваний. Врач 2001; 7: 3-6).</mixed-citation><mixed-citation xml:lang="en">Oganov RG. The concept of risk factors as a basis of prevention of cardiovascular diseases. Vrach 2001; 7: 3-6. Russian (Оганов Р. Г. Концепция факторов риска как основа профилактики сердечно-сосудистых заболеваний. Врач 2001; 7: 3-6).</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Greenland P, Knoll MD, Stamler, et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 2003; 290(7): 891-7.</mixed-citation><mixed-citation xml:lang="en">Greenland P, Knoll MD, Stamler, et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 2003; 290(7): 891-7.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">D'Agostino RB, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care the Framingham Heart Study. Circulation 2008; 117(6): 743-53.</mixed-citation><mixed-citation xml:lang="en">D'Agostino RB, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care the Framingham Heart Study. Circulation 2008; 117(6): 743-53.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Shal'nova SA, Deev AD, Oganov RG. Factors influencing mortality from cardiovascular disease in the Russian population. Cardiovascular Therapy and Prevention 2005; 1: 4-8 Russian (Шальнова С. А., Деев А. Д., Оганов Р. Г. Факторы, влияющие на смертность от сердечно-сосудистых заболеваний в российской популяции. Кардиоваскулярная терапия и профилактика 2005; 1: 4-8).</mixed-citation><mixed-citation xml:lang="en">Shal'nova SA, Deev AD, Oganov RG. Factors influencing mortality from cardiovascular disease in the Russian population. Cardiovascular Therapy and Prevention 2005; 1: 4-8 Russian (Шальнова С. А., Деев А. Д., Оганов Р. Г. Факторы, влияющие на смертность от сердечно-сосудистых заболеваний в российской популяции. Кардиоваскулярная терапия и профилактика 2005; 1: 4-8).</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Wilson PWF, D'Agostino RB, Levy D6 et al. Prediction of Coronary Heart Disease Using Risk Factor Categories. Circulation 1998;97(18):1837-47.</mixed-citation><mixed-citation xml:lang="en">Wilson PWF, D'Agostino RB, Levy D6 et al. Prediction of Coronary Heart Disease Using Risk Factor Categories. Circulation 1998;97(18):1837-47.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 200; 24(11): 987-1003.</mixed-citation><mixed-citation xml:lang="en">Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 200; 24(11): 987-1003.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Oganov RG, Shal'nova SA, Kalinina AM, et al. A new way to assess individual cardiovascular total risk for the population of Russia. Kardiologiia 2008; 5: 87-91. Russian (Оганов Р. Г., Шальнова С. А., Калинина А. М. и др. Новый способ оценки индивидуального сердечно-сосудистого суммарного риска для населения России. Кардиология 2008; 5: 87-91).</mixed-citation><mixed-citation xml:lang="en">Oganov RG, Shal'nova SA, Kalinina AM, et al. A new way to assess individual cardiovascular total risk for the population of Russia. Kardiologiia 2008; 5: 87-91. Russian (Оганов Р. Г., Шальнова С. А., Калинина А. М. и др. Новый способ оценки индивидуального сердечно-сосудистого суммарного риска для населения России. Кардиология 2008; 5: 87-91).</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Assmann G, Cullen P, Schulte H. The MQnster Heart Study (PROCAM). Results of follow-up at 8 years. Eur Heart J 1998;19 Suppl A: A2-11.</mixed-citation><mixed-citation xml:lang="en">Assmann G, Cullen P, Schulte H. The MQnster Heart Study (PROCAM). Results of follow-up at 8 years. Eur Heart J 1998;19 Suppl A: A2-11.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Conroy RM., Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europa: the SCORE project. Eur Heart J 2003; 24: 987¬1003.</mixed-citation><mixed-citation xml:lang="en">Conroy RM., Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europa: the SCORE project. Eur Heart J 2003; 24: 987¬1003.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by re. Eur Heart J 2012; 33(13): 1635-701.</mixed-citation><mixed-citation xml:lang="en">Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by re. Eur Heart J 2012; 33(13): 1635-701.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Oganov RG, Fomina IG. Cardiology. Guide for physicians. M .: Medicine. 2004; 852 p. Russian (Оганов Р. Г., Фомина И.Г. Кардиология. Руководство для врачей. М.: Изд-во Медицина 2004; 852 c).</mixed-citation><mixed-citation xml:lang="en">Oganov RG, Fomina IG. Cardiology. Guide for physicians. M .: Medicine. 2004; 852 p. Russian (Оганов Р. Г., Фомина И.Г. Кардиология. Руководство для врачей. М.: Изд-во Медицина 2004; 852 c).</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Hjemdahl P, Eriksson S V, Held C, et al. Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS). Heart. 2006; 92(2): 177-82.</mixed-citation><mixed-citation xml:lang="en">Hjemdahl P, Eriksson S V, Held C, et al. Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS). Heart. 2006; 92(2): 177-82.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Fox K, Garcia MAA, Ardissino D, et al. Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006; 27(11): 1341-81.</mixed-citation><mixed-citation xml:lang="en">Fox K, Garcia MAA, Ardissino D, et al. Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006; 27(11): 1341-81.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Goraya TY, Jacobsen SJ, Pellikka PA, et al. Prognostic value of treadmill exercise testing in elderly persons. Ann Intern Med 2000; 132: 862-70.</mixed-citation><mixed-citation xml:lang="en">Goraya TY, Jacobsen SJ, Pellikka PA, et al. Prognostic value of treadmill exercise testing in elderly persons. Ann Intern Med 2000; 132: 862-70.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Kansal S, Roitmam D, Bradley E, Sheffield LT. Enhanced evaluation of treadmill tests by means of scoring based on multivariate analysis and its clinical application: a study of 608 patients. Am J Cardiol 1983; 52: 1155-60.</mixed-citation><mixed-citation xml:lang="en">Kansal S, Roitmam D, Bradley E, Sheffield LT. Enhanced evaluation of treadmill tests by means of scoring based on multivariate analysis and its clinical application: a study of 608 patients. Am J Cardiol 1983; 52: 1155-60.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Aktas MK, Ozduran V, Pothier CE, et al. Global risk scores and exercise testing for predicting all-cause mortality in a preventive medicine program. JAMA 2004; 292: 1462-8.</mixed-citation><mixed-citation xml:lang="en">Aktas MK, Ozduran V, Pothier CE, et al. Global risk scores and exercise testing for predicting all-cause mortality in a preventive medicine program. JAMA 2004; 292: 1462-8.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Marcevich SJu, Vygodin VA, Metelica VI, et al. Selection of the optimal dose of longacting nitrates with the help of exercise test in patients with exertional angina Ter Arch 1981; 12:22-26. Russian (Марцевич С. Ю., Выгодин В. А., Метелица В. И. и др. Выбор оптимальной дозы нитратов пролонгированного действия с помощью теста с физической нагрузкой у больных стенокардией напряжения Тер архив 1981; 12: 22-6).</mixed-citation><mixed-citation xml:lang="en">Marcevich SJu, Vygodin VA, Metelica VI, et al. Selection of the optimal dose of longacting nitrates with the help of exercise test in patients with exertional angina Ter Arch 1981; 12:22-26. Russian (Марцевич С. Ю., Выгодин В. А., Метелица В. И. и др. Выбор оптимальной дозы нитратов пролонгированного действия с помощью теста с физической нагрузкой у больных стенокардией напряжения Тер архив 1981; 12: 22-6).</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Kokurina EV, Kukushkin SK. The combination of antianginal drugs in patients with angina pectoris. Kardiologiia 1991; 31; 9: 8084. Russian (Кокурина Е. В., Кукушкин С. К. Комбинация антиангинальных препаратов у больных со стенокардией. Кардиология 1991; 31; 9: 8084).</mixed-citation><mixed-citation xml:lang="en">Kokurina EV, Kukushkin SK. The combination of antianginal drugs in patients with angina pectoris. Kardiologiia 1991; 31; 9: 8084. Russian (Кокурина Е. В., Кукушкин С. К. Комбинация антиангинальных препаратов у больных со стенокардией. Кардиология 1991; 31; 9: 8084).</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Marcevich SJu, Metelica VI. Isosorbide dinitrate: dependency antianginal effect of the dosage form and dose. Ter Arch 1988; 60; 8: 27-30. Russian (Марцевич С. Ю., Метелица В. И. Изосорбида динитрат: зависимость антиангинального эффекта от лекарственной формы и дозы препарата. Тер архив 1988; 60; 8: 27-30).</mixed-citation><mixed-citation xml:lang="en">Marcevich SJu, Metelica VI. Isosorbide dinitrate: dependency antianginal effect of the dosage form and dose. Ter Arch 1988; 60; 8: 27-30. Russian (Марцевич С. Ю., Метелица В. И. Изосорбида динитрат: зависимость антиангинального эффекта от лекарственной формы и дозы препарата. Тер архив 1988; 60; 8: 27-30).</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Marcevich SJu, Shokarova SSh, Metelica VI. Tolerance to the antianginal effect of nitrates. Approaches to the study. Ter Arch 1984; 9:46-55. Russian (Марцевич С. Ю., Шокарова С. Ш., Метелица В. И. Толерантность к антиангинальному эффекту нитратов. Подходы к изучению. Тер архив 1984; 9: 46-55).</mixed-citation><mixed-citation xml:lang="en">Marcevich SJu, Shokarova SSh, Metelica VI. Tolerance to the antianginal effect of nitrates. Approaches to the study. Ter Arch 1984; 9:46-55. Russian (Марцевич С. Ю., Шокарова С. Ш., Метелица В. И. Толерантность к антиангинальному эффекту нитратов. Подходы к изучению. Тер архив 1984; 9: 46-55).</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Kokurina EV, Bochkareva EV, Marcevich SJu, et al. Methodological approaches to assessing the effectiveness of antianginal drugs in patients with stable angina using paired bicycle exercise stress. Kardiologiia 1985; 4: 35-41. Russian (Кокурина Е. В., Бочкарева Е. В., Марцевич С. Ю. и др. Методические подходы к оценке эффективности антиангинальных препаратов у больных со стабильной стенокардией с помощью парных велоэргометрических нагрузок. Кардиология 1985; 4: 35-41).</mixed-citation><mixed-citation xml:lang="en">Kokurina EV, Bochkareva EV, Marcevich SJu, et al. Methodological approaches to assessing the effectiveness of antianginal drugs in patients with stable angina using paired bicycle exercise stress. Kardiologiia 1985; 4: 35-41. Russian (Кокурина Е. В., Бочкарева Е. В., Марцевич С. Ю. и др. Методические подходы к оценке эффективности антиангинальных препаратов у больных со стабильной стенокардией с помощью парных велоэргометрических нагрузок. Кардиология 1985; 4: 35-41).</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Kukushkin SK, Kokurina EV, Metelica VI, et al. Screening of single doses of nitrates, calcium channel blockers, beta-blockers and their combinations in patients with angina pectoris by paired cycle ergometer. Ter Arch 1993; 65; 4: 43-9. Russian (Кукушкин С. К., Кокурина Е. В., Метелица В. И. и др. Скрининг разовых доз нитратов, антагонистов кальция, бета-адреноблокаторов и их комбинаций у больных со стенокардией напряжения методом парных велоэргометрий Терархив 1993; 65; 4: 43-9).</mixed-citation><mixed-citation xml:lang="en">Kukushkin SK, Kokurina EV, Metelica VI, et al. Screening of single doses of nitrates, calcium channel blockers, beta-blockers and their combinations in patients with angina pectoris by paired cycle ergometer. Ter Arch 1993; 65; 4: 43-9. Russian (Кукушкин С. К., Кокурина Е. В., Метелица В. И. и др. Скрининг разовых доз нитратов, антагонистов кальция, бета-адреноблокаторов и их комбинаций у больных со стенокардией напряжения методом парных велоэргометрий Терархив 1993; 65; 4: 43-9).</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Parmley WW. Prevalence and clinical significance of silent myocardial ischemia. Circulation 1989; 80(6 Suppl):IV68-73.</mixed-citation><mixed-citation xml:lang="en">Parmley WW. Prevalence and clinical significance of silent myocardial ischemia. Circulation 1989; 80(6 Suppl):IV68-73.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">The Working Group KIAP. Kardiologiia 1989; 2: 38-42. Russian (Рабочая группа КИАП. Кардиология 1989; 2: 38-42).</mixed-citation><mixed-citation xml:lang="en">The Working Group KIAP. Kardiologiia 1989; 2: 38-42. Russian (Рабочая группа КИАП. Кардиология 1989; 2: 38-42).</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">CSC revision 2008. National guidelines for the diagnosis and treatment of stable angina. Cardiovascular Therapy and Prevention 2008; 7; 6:Annex 4. Russian (РКО пересмотр 2008. Национальные рекомендации по диагностике и лечению стабильной стенокардии. Кардиоваскулярная терапия и профилактика 2008; 7; 6: Приложение 4).</mixed-citation><mixed-citation xml:lang="en">CSC revision 2008. National guidelines for the diagnosis and treatment of stable angina. Cardiovascular Therapy and Prevention 2008; 7; 6:Annex 4. Russian (РКО пересмотр 2008. Национальные рекомендации по диагностике и лечению стабильной стенокардии. Кардиоваскулярная терапия и профилактика 2008; 7; 6: Приложение 4).</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013; 34; 38: 2949-3003.</mixed-citation><mixed-citation xml:lang="en">Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013; 34; 38: 2949-3003.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF / AHA / ACP / AATS / PCNA / SCAI / STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation / American Heart Association task force on practice guidelines, and the. Circulation 2012; 126; 25:e354-471.</mixed-citation><mixed-citation xml:lang="en">Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF / AHA / ACP / AATS / PCNA / SCAI / STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation / American Heart Association task force on practice guidelines, and the. Circulation 2012; 126; 25:e354-471.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Kokurina EV, Bochkareva EV, Marcevich SJu, et al. Methodological approaches to assessing the effectiveness of antianginal drugs in patients with angina using paired bicycle exercise stress. Kardiologiia 1985; 10:35-40. Russian (Кокурина Е. В., Бочкарева Е. В., Марцевич С. Ю. и др. Методические подходы к оценке эффективности антиангинальных препаратов у больных со стенокардией с помощью парных велоэргометрических нагрузок. Кардиология 1985; 10: 35-40).</mixed-citation><mixed-citation xml:lang="en">Kokurina EV, Bochkareva EV, Marcevich SJu, et al. Methodological approaches to assessing the effectiveness of antianginal drugs in patients with angina using paired bicycle exercise stress. Kardiologiia 1985; 10:35-40. Russian (Кокурина Е. В., Бочкарева Е. В., Марцевич С. Ю. и др. Методические подходы к оценке эффективности антиангинальных препаратов у больных со стенокардией с помощью парных велоэргометрических нагрузок. Кардиология 1985; 10: 35-40).</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">The Working Group KIAP. Kardiologiia 1987; 1: 50-54. Russian (Рабочая группа КИАП. Кардиология 1987; 1: 50-4).</mixed-citation><mixed-citation xml:lang="en">The Working Group KIAP. Kardiologiia 1987; 1: 50-54. Russian (Рабочая группа КИАП. Кардиология 1987; 1: 50-4).</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">The Working Group KIAP. Kardiologiia 1987; II: 73-7. Russian (Рабочая группа КИАП. Кардиология 1987; II: 73-7).</mixed-citation><mixed-citation xml:lang="en">The Working Group KIAP. Kardiologiia 1987; II: 73-7. Russian (Рабочая группа КИАП. Кардиология 1987; II: 73-7).</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Wilson PWF, D’Agostino R, Bhatt DL, et al. An international model to predict recurrent cardiovascular disease. Am J Med 2012;125(7):695-703.e1.</mixed-citation><mixed-citation xml:lang="en">Wilson PWF, D’Agostino R, Bhatt DL, et al. An international model to predict recurrent cardiovascular disease. Am J Med 2012;125(7):695-703.e1.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Weiner DA, Ryan TJ, McCabe CH, et al. Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease. JACC 1984; 3(3): 772-9.</mixed-citation><mixed-citation xml:lang="en">Weiner DA, Ryan TJ, McCabe CH, et al. Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease. JACC 1984; 3(3): 772-9.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Califf RM, Mark DB, Harrell FE, et al. Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease. JACC 1988; 11(1): 20-6.</mixed-citation><mixed-citation xml:lang="en">Califf RM, Mark DB, Harrell FE, et al. Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease. JACC 1988; 11(1): 20-6.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Aronov DM, Lupanov VP, Sharfnadel MG, et al. The classification of functional status of patients with coronary artery disease Peter and Paul Fortress on the results of the exercise test. Ter archive 1980; 1: 19-22. Russian (Аронов Д. М., Лупанов В. П., Шарфнадель М. Г. и др. Классификация функционального состояния больных ишемической болезнью cердца по результатам пробы с физической нагрузкой. Тер архив 1980; 1: 19-22).</mixed-citation><mixed-citation xml:lang="en">Aronov DM, Lupanov VP, Sharfnadel MG, et al. The classification of functional status of patients with coronary artery disease Peter and Paul Fortress on the results of the exercise test. Ter archive 1980; 1: 19-22. Russian (Аронов Д. М., Лупанов В. П., Шарфнадель М. Г. и др. Классификация функционального состояния больных ишемической болезнью cердца по результатам пробы с физической нагрузкой. Тер архив 1980; 1: 19-22).</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Gasilin VS, Sidorenko BA. Angina pectoris. 2nd ed. Moscow: “Medicine” 1987; 240. Russian (Гасилин В. С., Сидоренко Б. А. Стенокардия. 2-е изд. Москва: “Медицина” 1987; 240 с).</mixed-citation><mixed-citation xml:lang="en">Gasilin VS, Sidorenko BA. Angina pectoris. 2nd ed. Moscow: “Medicine” 1987; 240. Russian (Гасилин В. С., Сидоренко Б. А. Стенокардия. 2-е изд. Москва: “Медицина” 1987; 240 с).</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Reeves TJ, Oberman A, Jones WB, Sheffield LT. Natural history of angina pectoris. Am J Cardiol 1974; 33: 423-30).</mixed-citation><mixed-citation xml:lang="en">Reeves TJ, Oberman A, Jones WB, Sheffield LT. Natural history of angina pectoris. Am J Cardiol 1974; 33: 423-30).</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Mark DB, Hlatky MA, Harrell FE, et al. Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med 1987; 106: 793-800.</mixed-citation><mixed-citation xml:lang="en">Mark DB, Hlatky MA, Harrell FE, et al. Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med 1987; 106: 793-800.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000; 355: 253-9.</mixed-citation><mixed-citation xml:lang="en">Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000; 355: 253-9.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
